Literature DB >> 12559171

Proteomics in translational cancer research: toward an integrated approach.

Julio E Celis1, Pavel Gromov.   

Abstract

Proteomics provides powerful tools for the study of clinically relevant samples in the context of translational cancer research. Here we briefly review applications of gel-based proteomics for the study of bladder and lung cancer using fresh tissue biopsies. In general, these studies have emphasized the potential of the technology for biomarker discovery, as well as for addressing the issue of cancer heterogeneity.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12559171     DOI： 10.1016/s1535-6108(02)00242-8

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  33 in total

Review 1.  Molecular imaging by mass spectrometry--looking beyond classical histology.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

2.  Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma.

Authors:  Kristina Schwamborn; René C Krieg; Peggy Jirak; German Ott; Ruth Knüchel; Andreas Rosenwald; Axel Wellmann
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-21       Impact factor: 4.553

Review 3.  Genomics and proteomics: role in the management of multiple sclerosis.

Authors:  Ludwig Kappos; Lutz Achtnichts; Frank Dahlke; Jens Kuhle; Y Naegelin; Rupert Sandbrink; Raija L P Lindberg
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

4.  Clinical proteomics: present and future prospects.

Authors:  Nicole M Verrills
Journal:  Clin Biochem Rev       Date:  2006-05

Review 5.  Proteomic technology for biomarker profiling in cancer: an update.

Authors:  Moulay A Alaoui-Jamali; Ying-jie Xu
Journal:  J Zhejiang Univ Sci B       Date:  2006-06       Impact factor: 3.066

Review 6.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

7.  Mass Defect-Based N,N-Dimethyl Leucine Labels for Quantitative Proteomics and Amine Metabolomics of Pancreatic Cancer Cells.

Authors:  Ling Hao; Jillian Johnson; Christopher B Lietz; Amanda Buchberger; Dustin Frost; W John Kao; Lingjun Li
Journal:  Anal Chem       Date:  2017-01-04       Impact factor: 6.986

Review 8.  Current application of proteomics in biomarker discovery for inflammatory bowel disease.

Authors:  Patrick Py Chan; Valerie C Wasinger; Rupert W Leong
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

9.  Impact of warm ischemia on phosphorylated biomarkers in head and neck squamous cell carcinoma.

Authors:  Jacob I Tower; Mark W Lingen; Tanguy Y Seiwert; Alexander Langerman
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

10.  Enrichment and proteomic analysis of plasma membrane from rat dorsal root ganglions.

Authors:  Xia Xiong; Sha Huang; Hai Zhang; Jianjun Li; Jianying Shen; Jixian Xiong; Yong Lin; Liping Jiang; Xianchun Wang; Sonping Liang
Journal:  Proteome Sci       Date:  2009-11-05       Impact factor: 2.480
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.